Navigation Links
Biotel Announces Strong Results for the Second Quarter Ended December 31, 2007
Date:2/11/2008

MINNEAPOLIS, Feb. 11 /PRNewswire-FirstCall/ -- Biotel Inc. (OTC Bulletin Board: BTEL.OB) announced strong sales and earnings for its second quarter ended December 31, 2007. The Company had net earnings of $206,000, or $0.07 per diluted share, on revenues of $2,859,000. This compares to net earnings of $120,000, or $0.04 per diluted share, on revenues of $2,705,000 for the second quarter of last year. For the six months ended December 31, 2007, Biotel had net earnings of $376,000, or $0.13 per diluted share, on revenues of $5,610,000. This compares to net earnings of $109,000, or $0.04 per share, on revenues of $5,129,000 for the firsts six months last year.

Highlights for the second quarter are as follows:

-- 5.7% revenue growth, year over year

-- Gross margin of 44.7%, up from 40.2% a year ago

-- Operating margin of 11.1% versus 7.2% a year ago

-- Net margin of 7.2% versus 4.4% a year ago

-- Strong balance sheet with no long-term debt

-- Stockholders' equity of $4,333,000, up 25.2% year over year

"We are pleased with our business progress in the second quarter, achieving strong improvement in margins as well as year over year growth in product and service revenues," Biotel President and CEO Steve Springrose said. "Underlying these results were strong sales of our Braemar cardiac event recorders, Holter devices, liposuction and other medical devices. On top of this, revenues from our Agility 24/7 cardiac monitoring services continued to grow, and the service component of our business contributed significantly to gross margin improvement. Year-over year growth in R&D continued to support our new product pipeline, including the ER900 Wireless Event Recorder, as well as other new cardiac event and Holter recorders. In keeping with our long-term strategy, Biotel continues to serve as a development partner to medical corporations seeking new devices and clinical research services."

3 months ended 3 months ended %

December 31, 2007 December 31, 2006 Change

Revenues $2,859,000 $2,705,000 5.7 %

Net Income $206,000 $120,000 71.7 %

Earnings Per Share, Basic $.08 $0.04

Earnings Per Share, Diluted $.07 $0.04

6 months ended 6 months ended %

December 31, 2007 December 31, 2006 Change

Revenues $5,610,000 $5,129,000 9.4 %

Net Income $376,000 $109,000 245.0 %

Earnings Per Share, Basic $.14 $0.04

Earnings Per Share, Diluted $.13 $0.04


'/>"/>
SOURCE Biotel Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Biotel Announces Strong Results for the First Quarter Ended September 30, 2007, FDA 510(k) Clearance for the Braemar ER900 Wireless Event Recorder
2. Biotel Announces Record Revenues and Strong Earnings for the Fourth Quarter and Year Ended June 30, 2007
3. Lincare Holdings Inc. Announces Fourth Quarter and Year Ended 2007 Financial Results
4. Hanger Orthopedic Group, Inc. Announces an 11% Sales Increase and a 35% Increase in EPS to $0.23 for the Quarter Ended December 31, 2007, Compared to $0.17 in the Prior Year
5. URAC Announces Four More Companies in Process to Earn New Pharmacy Quality Management Accreditations
6. MGT Capital Investments, Inc. Announces Subsidiarys Preliminary Agreement to Acquire Maydeal.com
7. Dialysis Corporation of America Announces Opening of New Dialysis Center in Ohio
8. Rural/Metro Announces Results for Fiscal 2008 Second Quarter
9. Brookdale Senior Living Announces Changes in Senior Management and Board of Directors
10. Tubbs Jones Announces Over $36 Million in Construction Projects for Cleveland VA Hospital
11. NightHawk Radiology Holdings, Inc. Announces Time Change for Fourth Quarter and Full-Year 2007 Earnings Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... Richmond, BC (PRWEB) , ... April 25, 2017 , ... ... patients from Richmond, BC, who live with dental fear and require sedation to receive ... anxiety at ease during various procedures, from hygienic cleanings to oral surgery, at ...
(Date:4/25/2017)... , ... April 25, 2017 , ... ... they rely on contracted partners to help with process innovation in drug formulation ... drug formulation experience along with state-of-the-art analytical equipment in support of their development ...
(Date:4/25/2017)... MN (PRWEB) , ... April 25, 2017 , ... Buyers ... and recreational users to dispensaries and head shops –can’t help but be heartened by ... for the tell-tale cannabis odor aptly described as “skunk smell.” At last they ...
(Date:4/25/2017)... ... 25, 2017 , ... Emergency Physician and Distinguished Professor of Emergency Medicine Bentley ... in Writing, set to publish in summer 2017. , Dr. Bobrow, MD, FACEP, ... Arizona College of Medicine. He also serves as Medical Director for the Bureau of ...
(Date:4/25/2017)... ... April 25, 2017 , ... Amendia, Inc., designer, developer, and ... partnership with and platinum sponsorship of Global Spine Outreach (“GSO”), a charitable organization ... of complex spine deformity cases, particularly in children. , GSO’s focus is to ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 2017 Eyevensys, a private biotechnology ... gene expression technology that enables the safe, local, sustained ... a wide range of ophthalmic diseases, announces it has ... Regulatory Agency (MHRA) to advance its technology into clinical ... The ...
(Date:4/19/2017)... , April 19, 2017 Cardiology devices segment ... projected period The Cardiology Devices segment is likely ... US$ 15 Mn in 2018 over 2017. By the end ... market valuation close to US$ 700 Mn, expanding at a ... segment dominated the Asia Pacific reprocessed ...
(Date:4/19/2017)... NEW YORK , April 19, 2017 /PRNewswire/ ... This report on the prostate cancer ... of the global market. Increasing prevalence of prostate ... as innovation in the development of new drugs ... hormone-refractory prostate cancer drug due to lesser side ...
Breaking Medicine Technology: